Skip to main content
Livermore
Livermore
ZHEN

Commonwealth Equity Services, LLC

SEC CIK
0000312272
Latest filing
Jul 29, 2026

SUPN holding history

Supernus Pharmaceuticals, Inc. in every 13F filed by Commonwealth Equity Services, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SUPN overviewAll 13F holders of SUPNFull Q2 2026 holdings

Shares (Q2 2026)
9,698
Value
$451.1K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of SUPN by Commonwealth Equity Services, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20269,698$451.1K<0.1%+1,096+12.7%AddedHolders
Q1 20268,602$444.6K<0.1%−1,774−17.1%ReducedHolders
Q4 202510,376$515.7K<0.1%+1,910+22.6%AddedHolders
Q3 20258,466$405.0K<0.1%−1,229−12.7%ReducedHolders
Q2 20259,695$306.0K<0.1%+109+1.1%AddedHolders
Q1 20259,586$314.0K<0.1%−210−2.1%ReducedHolders
Q4 20249,796$354.0K<0.1%−454−4.4%ReducedHolders
Q3 202410,250$320.0K<0.1%+55+0.5%AddedHolders
Q2 202410,195$273.0K<0.1%+350+3.6%AddedHolders
Q1 20249,845$336.0K<0.1%−185−1.8%ReducedHolders
Q4 202310,030$290.0K<0.1%+382+4.0%AddedHolders
Q3 20239,648$266.0K<0.1%+197+2.1%AddedHolders
Q2 20239,451$284.0K<0.1%+550+6.2%AddedHolders
Q1 20238,901$322.0K<0.1%+200+2.3%AddedHolders
Q4 20228,701$310.0K<0.1%−1,518−14.9%ReducedHolders
Q3 202210,219$345.0K<0.1%−385−3.6%ReducedHolders
Q2 202210,604$306.0K<0.1%+181+1.7%AddedHolders
Q1 202210,423$336.0K<0.1%−286−2.7%ReducedHolders
Q4 202110,709$312.0K<0.1%−671−5.9%ReducedHolders
Q3 202111,380$303.0K<0.1%+1,440+14.5%AddedHolders
Q2 20219,940$306.0K<0.1%+362+3.8%AddedHolders
Q1 20219,578$250.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.